Clinical Trial

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

Study acronym: REAL Registry
Recruiting
View on ClinicalTrials.gov →
Summary
The primary purpose of this Registry is to assess procedural safety and long-term effectiveness of catheter ablations in the treatment of subjects with PAF, PsAF, and VA. The Registry will utilize real world clinical data obtained from the use of commercially available CARTO™ technologies under the authority of a health care practitioner within a legitimate practitioner-subject relationship. Data from the registry will be used to assess clinical outcomes, including procedural efficiency, safety, and long-term effectiveness of catheter ablation with novel technologies for arrhythmia patients.
Protocol Amendment History 20 amendments
This ClinicalTrials.gov record has been amended 20 times since 2019-09-10; most recent amendment 2026-07-07.
Status change: Enrolling by Invitation → Recruiting 2023-02-27
Trial Details
NCT Number NCT04088071
Lead Sponsor Heart Rhythm Clinical and Research Solutions, LLC
Collaborators: Biosense Webster, Inc.
Conditions Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Ventricular Arrhythmia
Enrollment 20,000 participants
Start Date 2018-01-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-09